0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD73

CD73

CD73 Molecule Information

Name:5-nucleotidase
Target Synonym:5 -nucleotidase;NT5E;Ecto-5 -nucleotidase;CD_antigen=CD73;5 -NT;NT5 ;NTE
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:7
Lastest Research Phase:Phase ?

CD73 Part of Bioactivity data

CD3-H82E3-ELISA
Biotinylated Human CD73, His,AvitagBiotinylated Human CD73, His,Avitag (Cat. No. CD3-H82E3) ELISA bioactivity

Immobilized Monoclonal Anti-Human CD73 Antibody, Human IgG1 at 5 μg/mL (100 μL/well) can bind Biotinylated Human CD73, His,Avitag (Cat. No. CD3-H82E3) with a linear range of 0.6-5 ng/mL (QC tested).

TG1-H82Qb-ELISA
Biotinylated Human Latent TGF-Beta 1, His,AvitagBiotinylated Human Latent TGF-Beta 1, His,Avitag (Cat. No. TG1-H82Qb) ELISA bioactivity

Immobilized Human ITGAV&ITGB6 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT6-H52E1) at 5 μg/mL (100 μL/well) can bind Biotinylated Human Latent TGF-Beta 1, His,Avitag (Cat. No. TG1-H82Qb) with a linear range of 0.5-4 ng/mL (QC tested).

CD73 Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
Cat. No. Species Product Description Structure Purity Feature
CD3-H82E3 Human Biotinylated Human CD73 / NT5E Protein, His,Avitag™
CD3-H82E3-structure
CD3-H82E3-sds
CD3-H82E3-elisa_1
CD3-M52H9 Mouse Mouse CD73 / NT5E Protein, His Tag
CD3-M52H9-structure
CD3-M52H9-sds
CD3-H52H7 Human Human CD73 / NT5E Protein, His Tag (HPLC-verified)
CD3-H52H7-structure
CD3-H52H7-sds
CD3-H52H7-hplc
CD3-H52H7-elisa_1
CD3-H52H7-elisa_2

cd73 Molecule Synonym Name

CD73,NT5E,5'-Nucleotidase,5'-NT,NT5,NTE

cd73 Molecule Background

5'-nucleotidase also known as NT5E, CD73,

cd73 References

CD73 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
CPI-006 CPI-006 Phase Ⅰ Corvus Triple negative breast cancer, Non small cell lung cancer (NSCLC), Renal cell carcinoma, Endometrial cancer, Squamous cell carcinoma of head and neck cancer (SCCHN), Colorectal cancer, Metastatic castration-resistant prostate cancer (mCRPC), Sarcoma, Bladder cancer, Ovarian cancer, Cervical carcinoma, Pancreatic cancer Details
Anti-CD73 monoclonal antibody (Bristol-Myers Squibb) Phase Ⅰ Bristol-Myers Squibb Cancer Details
TJ-004309 TJD-5; TJ-004309; TJ-4309 Phase Ⅰ I-MAB Biopharma, Tracon Pharma Solid tumours, Metastatic cancer Details
LY-3475070 LY-3475070 Phase Ⅰ Lilly Cancer Details
BMS-986179 BMS-986179 Phase Ⅱ Bristol-Myers Squibb Solid tumours Details
Oleclumab MEDI-9447 Phase Ⅱ MedImmune Non small cell lung cancer (NSCLC), Prostate cancer, Breast cancer, Ovarian cancer, Pancreatic cancer Details
AB-680 AB-680 Phase Ⅰ Arcus Biosciences Cancer Details
SRF-373 SRF-373; NZV-930 Phase Ⅰ Surface Oncology, Novartis Solid tumours Details

This web search service is supported by Google Inc.

totop